Genmab Announces U.S. Food and Drug Administration Granted Orphan-Drug Designation to Epcoritamab (DuoBody®-CD3xCD20) in Follic
8/3 13:31
Media Release COPENHAGEN , Denmark; March 8 , 2022 Genmab A/S ( Nasdaq: GMAB ) announ ced today that the U.S. Food and Drug Administration (FDA) has granted orphan-drug d esignation to the investigational medicine, epcorit a mab (DuoBody®-CD3xCD20) , for the treatment of follicular lymphoma (FL)....